Page last updated: 2024-08-25

epanolol and metoprolol

epanolol has been researched along with metoprolol in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's4 (33.33)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Rydén, L2
Blake, P; Lewis, JA1
Duncker, DJ; Gho, BC; McFalls, EO; Sassen, LM; Verdouw, PD1
Clark-Turner, N1
Corbeij, HM; Huige, MC; Kragten, JA; Vermeulen, A; Withagen, AJ1
Evans, T1
Kindermann, W; Kullmer, T; Singer, M1
Bjørnerheim, R; Erichsen, A; Golf, S; Hansson, V1
Borland, WW; Curzio, J; Farish, E; Lees, KR; Rubin, PC1
Alberti, KG; Boon, NA; MacGregor, IR; Perrie, AM; Riemersma, RA; Stenhouse, F; Wright, RA1

Trials

7 trial(s) available for epanolol and metoprolol

ArticleYear
Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
    Journal of internal medicine, 1992, Volume: 231, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Double-Blind Method; Exercise Test; Humans; Metoprolol; Physical Endurance; Physical Exertion; Propanolamines

1992
Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Drugs, 1989, Volume: 38 Suppl 2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Drug Tolerance; Female; Humans; Male; Metoprolol; Middle Aged; Multicenter Studies as Topic; Propanolamines

1989
Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
    Drugs, 1989, Volume: 38 Suppl 2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzeneacetamides; Exercise Test; Female; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Multicenter Studies as Topic; Propanolamines; Sweden

1989
Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
    Drugs, 1989, Volume: 38 Suppl 2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Benzeneacetamides; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Metoprolol; Propanolamines

1989
Effects on physical performance of intrinsic sympathomimetic activity (ISA) during selective beta 1-blockade.
    European journal of applied physiology and occupational physiology, 1987, Volume: 56, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Benzeneacetamides; Blood Glucose; Clinical Trials as Topic; Double-Blind Method; Heart Rate; Humans; Lactates; Male; Metoprolol; Oxygen Consumption; Physical Endurance; Potassium; Propanolamines; Random Allocation; Sympathetic Nervous System; Time Factors

1987
The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
    European journal of clinical pharmacology, 1987, Volume: 33, Issue:4

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Benzeneacetamides; Double-Blind Method; Heart Rate; Humans; Lactates; Male; Metoprolol; Middle Aged; Muscles; Physical Exertion; Propanolamines; Random Allocation

1987
The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
    European journal of clinical pharmacology, 1994, Volume: 46, Issue:3

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Glucose; Blood Pressure; Double-Blind Method; Humans; Insulin; Lipids; Male; Metoprolol; Nifedipine; Plasminogen Activator Inhibitor 1; Propanolamines; Risk Factors; Tissue Plasminogen Activator

1994

Other Studies

5 other study(ies) available for epanolol and metoprolol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Epanolol as a model for assessing patient preference in anti-anginal drug therapy.
    Journal of clinical pharmacology, 1992, Volume: 32, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Choice Behavior; Female; Humans; Male; Metoprolol; Middle Aged; Models, Biological; Nifedipine; Patient Compliance; Propanolamines; Quality of Life

1992
Effect of antiischemic therapy on coronary flow reserve and the pressure-maximal coronary flow relationship in anesthetized swine.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:6

    Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Benzeneacetamides; Blood Pressure; Coronary Circulation; Coronary Disease; Heart Rate; Metoprolol; Nifedipine; Propanolamines; Swine

1991
Left ventricular function during treatment with either metoprolol or epanolol.
    Drugs, 1989, Volume: 38 Suppl 2

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzeneacetamides; Blood Pressure; Heart Rate; Humans; Metoprolol; Propanolamines

1989
Relative selectivity of different beta-adrenoceptor antagonists for human heart beta 1- and beta 2-receptor subtypes assayed by a radioligand binding technique.
    Scandinavian journal of clinical and laboratory investigation, 1987, Volume: 47, Issue:7

    Topics: Adrenergic beta-Antagonists; Atenolol; Benzeneacetamides; Humans; Metoprolol; Myocardium; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta

1987